Arcutis Biotherapeutics Executives Sell 67,511 Shares Amid Trading

Arcutis Biotherapeutics, Inc. (ARQT) recently disclosed that Executive Vice President and Chief Medical Officer Burnett Patrick sold 3,675 shares at $25.5 per share on February 2, 2026, and 9,794 shares at $25.81 per share on February 4, 2026. EVP Chief Commercial Officer Edwards Larry Todd sold 2,052 shares at $25.5 per share on February 2, 2026, while SVP General Counsel and Corporate Secretary Matsuda Masaru sold 19,379 shares at $25.24 per share on February 2, 2026. Matsuda also sold 8,562 shares at $24.97 per share on February 2, 2026, 4,714 shares at $25.63 per share on February 2, 2026, and 7,983 shares at $25.5 per share on February 2, 2026. SVP Chief Financial Officer Vairavan Latha sold 1,320 shares at $25.5 per share on February 2, 2026, while Director, President, and Chief Executive Officer Watanabe Todd sold 19,833 shares at $25.5 per share on February 2, 2026. Finally, Director Welgus Howard G. sold 10,000 shares at $25.05 per share on February 2, 2026.